Abdelgawad, M.A.; Hayallah, A.M.; Bukhari, S.N.A.; Musa, A.; Elmowafy, M.; Abdel-Rahman, H.M.; Abd El-Gaber, M.K.
Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold. Pharmaceuticals 2022, 15, 1416.
https://doi.org/10.3390/ph15111416
AMA Style
Abdelgawad MA, Hayallah AM, Bukhari SNA, Musa A, Elmowafy M, Abdel-Rahman HM, Abd El-Gaber MK.
Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold. Pharmaceuticals. 2022; 15(11):1416.
https://doi.org/10.3390/ph15111416
Chicago/Turabian Style
Abdelgawad, Mohamed A., Alaa M. Hayallah, Syed Nasir Abbas Bukhari, Arafa Musa, Mohammed Elmowafy, Hamdy M. Abdel-Rahman, and Mohammed K. Abd El-Gaber.
2022. "Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold" Pharmaceuticals 15, no. 11: 1416.
https://doi.org/10.3390/ph15111416
APA Style
Abdelgawad, M. A., Hayallah, A. M., Bukhari, S. N. A., Musa, A., Elmowafy, M., Abdel-Rahman, H. M., & Abd El-Gaber, M. K.
(2022). Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold. Pharmaceuticals, 15(11), 1416.
https://doi.org/10.3390/ph15111416